Additional file 1: of Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

Závada, Jakub; Uher, Michal; Svobodová, Radka; Olejárová, Marta; Hušáková, Markéta; Ciferská, Hana; Hulejová, Hana; Tomčík, Michal; Šenolt, Ladislav; Vencovský, Jiří

doi:10.6084/m9.figshare.c.3608210_D2.v1

13075_2015_862_MOESM1_ESM.pdf (386.26 kB)

Additional file 1: of Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

journal contribution

posted on 2015-11-25, 05:00 authored by Jakub Závada, Michal Uher, Radka Svobodová, Marta Olejárová, Markéta Hušáková, Hana Ciferská, Hana Hulejová, Michal Tomčík, Ladislav Šenolt, Jiří Vencovský

Comparison of tenascin-C levels between males and females, and between female patients and female healthy controls. (PDF 386 kb)

Funding

Ministerstvo Zdravotnictví Ceské Republiky

History

Usage metrics

Keywords

Tenascin-C Biomarker SLE Disease activity Flare

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: of Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study

Funding

Ministerstvo Zdravotnictví Ceské Republiky

History

Usage metrics

Categories

Keywords

Licence

Exports